CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Passive investing can simplify retirement saving by lowering costs and smoothing returns. Learn why this approach often suits long-term goals vs active strategies.
23,287 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Bitunix unveils a Visa-powered debit card allowing users to spend crypto worldwide and earn yields. The card integrat...
Anthropic’s dispute with the Pentagon over ethical uses triggers a contract cancellation and a supply chain risk desi...
Investors often see a mixed day after defense-news headlines. This deep dive explains the kratos defense stock drop, ...
A university dean warns that AI's push for efficiency could erase entry-level roles for young workers, even as they d...
Aehr Test Systems stock jumped on Wednesday after a repeat order for automated wafer burn-in systems signaled growing...
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...
Billionaire investor Warren Buffett expanded his charity reach with a multi-billion-dollar donation this week, illust...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
In February, Fluor Corp. shares kept climbing as demand for infrastructure and energy projects stayed resilient. This...
When oil surges, mining companies feel the sting long before metals move. This article breaks down how energy costs p...